Mostra 1 - 1 risultati di 1 ricerca 'REPOSIT study group', tempo di risposta: 0,02s
Raffina i risultati
-
1
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characterist... di Bernies van der Hiel, John B.A.G. Haanen, Marcel P.M. Stokkel, Daniel S. Peeper, Connie R. Jimenez, Jos H. Beijnen, Bart A. van de Wiel, Ronald Boellaard, Alfons J.M. van den Eertwegh, REPOSIT study group
Pubblicazione 2017-09-01
Articolo